Retatrutide has emerged as a new treatment in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By stimulating https://umarxfqf246632.anchor-blog.com/16467112/tirzepatide-a-promising-new-treatment-for-obesity